NEOVACS: Update on voting rights and share capital

On June 3, 2025, the biopharmaceutical company NEOVACS, listed on Euronext Growth Paris under the ticker ALNEV, announced details of its share capital. As of May 31, 2025, the total number of shares and the number of gross and net voting rights amounted to 208,080,085. Since the beginning of 2025, the monthly issuance of new shares has been split between OCEANE, ORA, and other types, with a total of 133,429,743 shares issued in May alone.

NEOVACS also reminds us that its website is constantly updating its data on new share issues. It also provides warnings about potential dilution effects on the stock market and the impact on share value, highlighting the impact of financing in the form of OCEANE and ORA bonds.